Literature DB >> 15862170

Nerve growth factor and corneal wound healing in dogs.

Heung-Myong Woo1, Ellison Bentley, Sean F Campbell, Carl F Marfurt, Christopher J Murphy.   

Abstract

Nerve growth factor in the tear film and corneal epithelium is hypothesized to play an important role in ocular surface maintenance and corneal wound healing. The purpose of this study was to determine the expression of nerve growth factor and its high affinity (trkA) receptor in tears, cornea, and lacrimal glands of normal dogs, the modulation of nerve growth factor and its trkA receptor during corneal wound healing, and the effect of topical nerve growth factor application on canine corneal epithelial wound healing. In the first of three experiments, the nerve growth factor content of tears, corneal epithelium, lacrimal gland, and 3rd eyelid gland was determined in normal dogs by enzyme-linked immunosorbent assay and the expression of nerve growth factor and its trkA receptor were evaluated in the cornea and lacrimal glands by immunohistochemistry. In a second experiment, unilateral corneal epithelial defects were created, and tissues were evaluated for changes in nerve growth factor or trkA expression for 1 week. In a third experiment, bilateral corneal epithelial defects were created and the right eyes in each animal were treated 4 times daily with either recombinant human nerve growth factor, murine nerve growth factor, or nerve growth factor-blocking antibody. The results of this study showed that nerve growth factor levels in normal dog tears, corneal epithelium, third eyelid gland and lacrimal gland were 15.4+/-4.6 ng ml(-1), 33.5+/-12.3, 52.4+/-17.4 and 48.8+/-9.4 ng g(-1), respectively. NGF and trkA receptors were identified by immunohistochemistry in all tissues examined. After unilateral corneal wounding, nerve growth factor concentration increased in the tears bilaterally for 3 days, especially in the wounded eye, and then returned to pre-wounding values. Nerve growth factor content, and immunohistochemical staining for nerve growth factor and trkA, increased significantly in the ipsilateral cornea epithelium following unilateral wounding. Nerve growth factor concentrations in lacrimal and third eyelid glands also increased bilaterally (p<0.01) after unilateral wounding. Time to wound closure and rate of epithelial migration did not differ significantly between nerve growth factor-treated, nerve growth factor antibody-treated, and control eyes. In conclusion, nerve growth factor is present under resting physiologic conditions in normal canine tears, and nerve growth factor and its trkA receptor are present under resting conditions in normal canine corneal epithelium, lacrimal gland and third eyelid gland. Nerve growth factor is elevated in the tears, cornea, and lacrimal glands after corneal epithelial wounding; however, topical application of nerve growth factor, or its blocking antibody does not modulate corneal wound healing in the normal dog eye.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15862170     DOI: 10.1016/j.exer.2004.11.013

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  10 in total

1.  The TFOS International Workshop on Contact Lens Discomfort: report of the subcommittee on neurobiology.

Authors:  Fiona Stapleton; Carl Marfurt; Blanka Golebiowski; Mark Rosenblatt; David Bereiter; Carolyn Begley; Darlene Dartt; Juana Gallar; Carlos Belmonte; Pedram Hamrah; Mark Willcox
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-18       Impact factor: 4.799

2.  A fully caninised anti-NGF monoclonal antibody for pain relief in dogs.

Authors:  David P Gearing; Elena R Virtue; Robert P Gearing; Alexander C Drew
Journal:  BMC Vet Res       Date:  2013-11-09       Impact factor: 2.741

3.  Molecular markers for corneal epithelial cells in larval vs. adult Xenopus frogs.

Authors:  Surabhi Sonam; Jennifer A Srnak; Kimberly J Perry; Jonathan J Henry
Journal:  Exp Eye Res       Date:  2019-04-11       Impact factor: 3.467

4.  Shifting the IGF-axis: An age-related decline in human tear IGF-1 correlates with clinical signs of dry eye.

Authors:  Roshni Patel; Meifang Zhu; Danielle M Robertson
Journal:  Growth Horm IGF Res       Date:  2018-02-06       Impact factor: 2.372

5.  Nerve growth factor promotes corneal epithelial migration by enhancing expression of matrix metalloprotease-9.

Authors:  Tomas Blanco-Mezquita; Carmen Martinez-Garcia; Rui Proença; James D Zieske; Stefano Bonini; Alessandro Lambiase; Jesus Merayo-Lloves
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-04       Impact factor: 4.799

6.  Control of patterns of corneal innervation by Pax6.

Authors:  Lucy J Leiper; Jingxing Ou; Petr Walczysko; Romana Kucerova; Derek N Lavery; John D West; J Martin Collinson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-21       Impact factor: 4.799

7.  Topical administration of adrenergic receptor pharmaceutics and nerve growth factor.

Authors:  Jena J Steinle
Journal:  Clin Ophthalmol       Date:  2010-07-21

8.  Investigation of the human tear film proteome using multiple proteomic approaches.

Authors:  Kari B Green-Church; Kelly K Nichols; Nan M Kleinholz; Liwen Zhang; Jason J Nichols
Journal:  Mol Vis       Date:  2008-03-07       Impact factor: 2.367

9.  Nerve growth factor regulates neurolymphatic remodeling during corneal inflammation and resolution.

Authors:  Darci M Fink; Alicia L Connor; Philip M Kelley; Maria M Steele; Michael A Hollingsworth; Richard M Tempero
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

10.  Localization of the low-affinity nerve growth factor receptor p75 in human limbal epithelial cells.

Authors:  Nick Di Girolamo; Maria Sarris; Jeanie Chui; Haroon Cheema; Minas T Coroneo; Denis Wakefield
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.